http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE38169-E
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_38b1382f49f67ed77416e9bf085e9078 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3511 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 |
filingDate | 2000-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2003-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a8ec18a56b61d4a00226d483c2eaa7d |
publicationDate | 2003-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-RE38169-E |
titleOfInvention | Hyperstabilizing antisense nucleic acid binding agents |
abstract | Attaching certain ligands to antisense probes will hyperstabilize sense-antisense duplexes. Such a hyperstabilized duplex is resistant to melting of the strands from one another, to unwinding of the strands, and to the action of nucleases. Applications include antiretroviral action, antireverse-transcriptase action, antiviral action, antiparasitical action, antibacterial action, antifungal action, anticancer action, anti-oncogene action, and other applications where it is desired to inhibit gene expression at the genomic or messenger RNA level. The preferred ligands are certain minor-groove-binding agents, exemplified by CC-1065 and synthetic CC-1065 analogs. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005214797-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008293586-A1 |
priorityDate | 1993-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 219.